Non-clear cell renal cell carcinoma

Pembrolizumab Frontline Use With Lenvatinib Supported in nccRCC

Combining pembrolizumab (Keytruda) with lenvatinib (Lenvima) has showcased enduring effectiveness against tumors in patients with non-clear cell renal cell carcinoma ...